BPA for genetic testing for tripler army medical center, HI
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- W81K0225AA014
- Awardee
-
Fulgent Therapeutics LLC UEI JVZDRESJLD82 Part of Fulgent Genetics, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Genetic Testing Services for Tripler Army Medical Center, HI Solicitation · W81K0225QA024 · Posted Apr 7, 2025
- Last date to order 22% complete
- IDV ceiling
- $500,000.00
- Maximum order
- $25,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency established a Blanket Purchase Agreement with Fulgent Therapeutics LLC on September 8, 2025, with a $500,000 ceiling for genetic testing services at Tripler Army Medical Center in Hawaii.
The BPA covers comprehensive genetic testing across multiple medical specialties, including next-generation sequencing, consultation, and result interpretation for pathology specimens. Services span cardiology, dermatology, hematology, hereditary cancer, and other specialties, with standard turnaround times of 21 calendar days for most tests. Fulgent Therapeutics must maintain CLIA and CAP accreditation with at least two years of CAP oversight and is responsible for specimen packaging, shipping materials, and patient confidentiality compliance.
The BPA runs from September 8, 2025, through September 7, 2030, with a per-call limit of $25,000. Place of performance is Tripler Army Medical Center, Hawaii. The multiple-award procurement was awarded under open competition with no set-aside designation at NAICS code 621511 (medical and diagnostic laboratory services).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0225AA014?
W81K0225AA014 was awarded to Fulgent Therapeutics LLC by Defense Health Agency (Department of Defense) on September 8, 2025.
How much is contract W81K0225AA014 worth?
W81K0225AA014's own ceiling is $500,000. A single order can be worth up to $25,000.
Who can order from contract W81K0225AA014?
W81K0225AA014 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV